Normal Double Patenting Rules Don’t Apply When the Patents Straddle the URAA
In Novaritis Pharmaceuticals Corporation v. Breckenridge Pharmaceutical Inc., [2017-2173, 2017-2175, 2017-2176, 2017-2178, 2017-2179, 2017-2180, 2017-2182, 2017-2183, 2017-2184] (December 7, 2018), the Federal Circuit reversed the district court, determining that the law of obviousness-type double patenting does not require a patent owner to … Continue reading Normal Double Patenting Rules Don’t Apply When the Patents Straddle the URAA
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed